To evaluate the role of FBXO22 on tumorigenesis, we showed that knockdown of FBXO22 in SW620 cells by shRNA dramatically suppressed subcutaneous tumor growth (Fig. 4g, h). Here, FBXO22 is linked to neoplasm.